Literature DB >> 12622775

Monoclonal antibodies to denatured human ACE (CD 143), broad species specificity, reactivity on paraffin sections, and detection of subtle conformational changes in the C-terminal domain of ACE.

I V Balyasnikova1, R Metzger, F E Franke, S M Danilov.   

Abstract

Two new mouse monoclonal antibodies (mAbs) were generated to denatured human angiotensin-converting enzyme (ACE, CD143). The clones 2E2 and 3C5, each of the IgG1 kappa chain isotype, detect ACE with high sensitivity, respectively, at 20 ng and 2 ng of protein per lane in Western blotting. They both recognize different epitopes on the C-domain of ACE located between amino acid residues 740 and 992. In formalin-fixed and paraffin-embedded human tissues, immunohistochemistry revealed all known expression sites of ACE, e.g. the epithelial brush borders of proximal kidney tubules, epithelial cells of epididymis, endothelial cells, activated macrophages as well as germ cells during spermatogenesis. In contrast to other mAbs to denatured human ACE, mAbs 2E2 and 3C5 demonstrate cross-reactivity with a broad spectrum of animal species such as monkey, rat, rabbit, cattle, dog, cat, and guinea pig. In addition, mAb 2E2 recognized mouse ACE in Western blotting and on paraffin sections. Our findings suggest that mAbs 2E2 and 3C5 are useful for identifying even subtle changes in ACE conformation resulting from denaturation. These mAbs are also sensitive tools for the detection of minimal amounts of ACE in biological fluids and tissues using proteomics approaches. Their reactivity in routinely processed tissues of various species may prove useful for correlation of ACE expression in animal models to human diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622775     DOI: 10.1034/j.1399-0039.2003.610104.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain.

Authors:  Sergei M Danilov; Sergey Kalinin; Zhenlong Chen; Elena I Vinokour; Andrew B Nesterovitch; David E Schwartz; Olivier Gribouval; Marie-Claire Gubler; Richard D Minshall
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

2.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

3.  A novel splice-site mutation in angiotensin I-converting enzyme (ACE) gene, c.3691+1G>A (IVS25+1G>A), causes a dramatic increase in circulating ACE through deletion of the transmembrane anchor.

Authors:  Alexandre Persu; Michel Lambert; Jaap Deinum; Marta Cossu; Nathalie de Visscher; Leonid Irenge; Jerôme Ambroise; Jean-Marc Minon; Andrew B Nesterovitch; Alexander Churbanov; Isolda A Popova; Sergei M Danilov; A H Jan Danser; Jean-Luc Gala
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

4.  Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.

Authors:  Nicola E Clarke; Martin J Fisher; Karen E Porter; Daniel W Lambert; Anthony J Turner
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

5.  An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding.

Authors:  Sergei M Danilov; Kerry Gordon; Andrew B Nesterovitch; Heinrich Lünsdorf; Zhenlong Chen; Maricela Castellon; Isolda A Popova; Sergey Kalinin; Emma Mendonca; Pavel A Petukhov; David E Schwartz; Richard D Minshall; Edward D Sturrock
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

6.  Epitope mapping of novel monoclonal antibodies to human angiotensin I-converting enzyme.

Authors:  Isolda A Popova; Lizelle Lubbe; Pavel A Petukhov; Gavriil F Kalantarov; Ilya N Trakht; Elena R Chernykh; Olga Y Leplina; Alex V Lyubimov; Joe G N Garcia; Steven M Dudek; Edward D Sturrock; Sergei M Danilov
Journal:  Protein Sci       Date:  2021-05-11       Impact factor: 6.993

7.  Intrarenal distributions and changes of Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 in feline and canine chronic kidney disease.

Authors:  Sawane Mitani; Akira Yabuki; Mariko Sawa; Hye-Sook Chang; Osamu Yamato
Journal:  J Vet Med Sci       Date:  2013-09-05       Impact factor: 1.267

8.  Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.

Authors:  Geoffrey Masuyer; Ross G Douglas; Edward D Sturrock; K Ravi Acharya
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

9.  Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE).

Authors:  Christopher J Yates; Geoffrey Masuyer; Sylva L U Schwager; Mohd Akif; Edward D Sturrock; K Ravi Acharya
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

10.  Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.

Authors:  Kate M Larmuth; Geoffrey Masuyer; Ross G Douglas; Sylva L Schwager; K Ravi Acharya; Edward D Sturrock
Journal:  FEBS J       Date:  2016-02-09       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.